Leica Biosystems Announces Partnership with Indica Labs to Offer Integrated Digital Pathology Workflow Solutions to Mutual Customers


Indica Labs, the leader in computational and image management software for digital pathology, and Leica Biosystems, a specialist in cancer diagnostics and a world leader in workflow solutions, today announced a cooperation to deliver interoperable digital pathology workflow solutions.

Indica Labs’ Halo family of software products, which includes AI-assisted image analysis and image management workflow software, will continue to be compatible with Leica Biosystems’ Aperio GT 450 series of scanners. This agreement establishes a relationship between the two companies.

“The Indica team is pleased to formalize our relationship with Leica Biosystems. The partnership underscores our commitment to connect Leica Biosystems’ state-of-the-art slide scanners, reagents and instruments with our leading digital workflow and analysis software”, “Our customers can rest assured that both companies are proactive in this working to meet the regulatory and technical integration needs of the industry.”

Steven Hashagen , CEO of Indica Labs


“For customers using Leica Biosystems’ Aperio GT 450 family platforms and looking for AI-enabled image analysis and image management applications, this new partnership can eliminate integration issues and provide our customers with the confidence to implement a digital pathology workflow with the HALO product portfolio of Indica,”

Gustavo Perez , President of Leica Biosystems

Next Post

Optimizing Wound Management in the Hospital and ASC Setting

Surgeons and ASCs face big financial risks as they take on orthopedic bundled payments. It was always important to deliver great patient outcomes and now the stability of the practice depends on it. But this isn’t entirely uncharted territory. Join orthopedic surgeons from the Rothman Institute, OrthoCarolina, Yale Medicine and […]